TY - JOUR
T1 - The Effects of Acceptance and Commitment Therapy (ACT) Intervention on Inflammation and Stress Biomarkers
T2 - a Randomized Controlled Trial
AU - Järvelä-Reijonen, Elina
AU - Puttonen, Sampsa
AU - Karhunen, Leila
AU - Sairanen, Essi
AU - Laitinen, Jaana
AU - Kolehmainen, Mikko
AU - Pihlajamäki, Jussi
AU - Kujala, Urho M.
AU - Korpela, Riitta
AU - Ermes, Miikka
AU - Lappalainen, Raimo
AU - Kolehmainen, Marjukka
N1 - Funding Information:
Open access funding provided by University of Eastern Finland (UEF) including Kuopio University Hospital. The Elixir study was funded by the SalWe Research Program for Mind and Body (Tekes, the Finnish Funding Agency for Technology and Innovation grant 1104/10). The preparation of this paper was also funded by the PhD student position (EJ-R) in the Doctoral Programme in Nutrition of the Faculty of Health Sciences, University of Eastern Finland, and by personal grant (EJ-R) of Finnish Cultural Foundation, North Savo Regional fund. Acknowledgments
Funding Information:
We would like to thank all of the study participants for their valuable voluntary contribution; Johanna N?rv?inen (VTT Technical Research Centre of Finland Ltd., Kuopio, Finland) for the support with statistical programs; Maarit Hallikainen and Kristiina Juvonen (Institute of Public Health and Clinical Nutrition, Clinical Nutrition, University of Eastern Finland), Sanni Lindroos and Katri Peuhkuri (Medical Faculty, Pharmacology, Medical Nutrition Physiology, University of Helsinki), Sara Mutikainen and Tiina F?hr (Faculty of Sport and Health Sciences, University of Jyv?skyl?), Tero Myllym?ki (Department of Psychology, University of Jyv?skyl?), and Elina Mattila (VTT Technical Research Centre of Finland Ltd., Tampere, Finland) who contributed to the Elixir study design and data collection; Eeva Lajunen, Erja Kinnunen, and Maritta Putkiranta for their skillful assistance in managing the study visits; Iina Gr?nberg, Saara V?h?kyl? (formerly Leino), Siniriikka Ventel?, and Raisa Harjula for their skillful participation in conducting the practical period and handling dietary data; and Sini L?hteenm?ki for data handling and revision, as well as Marianna Koivisto, Heidi Kinnunen (formerly Aaltonen), and Saara Peuhkuri for handling dietary data. We would also like to thank Salla Muuraiskangas for managing the electronic questionnaires of the Elixir study and Anni Helld?n (The National Institute for Health and Welfare, Helsinki, Finland) for giving advice on the 48-h dietary recall protocol development.
Publisher Copyright:
© 2020, The Author(s).
PY - 2020/5/11
Y1 - 2020/5/11
N2 - Background: Psychological processes can be manifested in physiological health. We investigated whether acceptance and commitment therapy (ACT), targeted on psychological flexibility (PF), influences inflammation and stress biomarkers among working-age adults with psychological distress and overweight/obesity. Method: Participants were randomized into three parallel groups: (1) ACT-based face-to-face (n = 65; six group sessions led by a psychologist), (2) ACT-based mobile (n = 73; one group session and mobile app), and (3) control (n = 66; only the measurements). Systemic inflammation and stress markers were analyzed at baseline, at 10 weeks after the baseline (post-intervention), and at 36 weeks after the baseline (follow-up). General PF and weight-related PF were measured with questionnaires (Acceptance and Action Questionnaire, Acceptance and Action Questionnaire for Weight-Related Difficulties). Results: A group × time interaction (p =.012) was detected in the high-sensitivity C-reactive protein (hsCRP) level but not in other inflammation and stress biomarkers. hsCRP decreased significantly in the face-to-face group from week 0 to week 36, and at week 36, hsCRP was lower among the participants in the face-to-face group than in the mobile group (p =.035, post hoc test). Age and sex were stronger predictors of biomarker levels at follow-up than the post-intervention PF. Conclusion: The results suggest that ACT delivered in group sessions may exert beneficial effects on low-grade systemic inflammation. More research is needed on how to best apply psychological interventions for the health of both mind and body among people with overweight/obesity and psychological distress. Trial Registration: ClinicalTrials.gov Identifier: NCT01738256, Registered 17 August, 2012.
AB - Background: Psychological processes can be manifested in physiological health. We investigated whether acceptance and commitment therapy (ACT), targeted on psychological flexibility (PF), influences inflammation and stress biomarkers among working-age adults with psychological distress and overweight/obesity. Method: Participants were randomized into three parallel groups: (1) ACT-based face-to-face (n = 65; six group sessions led by a psychologist), (2) ACT-based mobile (n = 73; one group session and mobile app), and (3) control (n = 66; only the measurements). Systemic inflammation and stress markers were analyzed at baseline, at 10 weeks after the baseline (post-intervention), and at 36 weeks after the baseline (follow-up). General PF and weight-related PF were measured with questionnaires (Acceptance and Action Questionnaire, Acceptance and Action Questionnaire for Weight-Related Difficulties). Results: A group × time interaction (p =.012) was detected in the high-sensitivity C-reactive protein (hsCRP) level but not in other inflammation and stress biomarkers. hsCRP decreased significantly in the face-to-face group from week 0 to week 36, and at week 36, hsCRP was lower among the participants in the face-to-face group than in the mobile group (p =.035, post hoc test). Age and sex were stronger predictors of biomarker levels at follow-up than the post-intervention PF. Conclusion: The results suggest that ACT delivered in group sessions may exert beneficial effects on low-grade systemic inflammation. More research is needed on how to best apply psychological interventions for the health of both mind and body among people with overweight/obesity and psychological distress. Trial Registration: ClinicalTrials.gov Identifier: NCT01738256, Registered 17 August, 2012.
KW - ACT
KW - Low-grade inflammation
KW - Mindfulness
KW - Obesity
KW - Psychological flexibility
KW - Stress
U2 - 10.1007/s12529-020-09891-8
DO - 10.1007/s12529-020-09891-8
M3 - Article
C2 - 32394219
AN - SCOPUS:85084458754
SN - 1070-5503
VL - 27
SP - 539
EP - 555
JO - INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE
JF - INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE
IS - 5
M1 - 3251
ER -